A review on recent pharmaceutical API trends in the Global Pharmaceutical Market:-

The global active pharmaceutical ingredients (API) market size was estimated at USD 237.47 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.75% from 2024 to 2030 ¹. Here are some key trends in the pharmaceutical API market:

- *Advancements in API manufacturing*: Innovations in technology and manufacturing processes are driving growth in the API market ¹.

- *Growth of the biopharmaceutical sector*: The increasing demand for biopharmaceuticals is leading to a rise in API production ¹.

- *Aging population*: The growing global geriatric population is driving demand for APIs, as older people are more likely to suffer from chronic diseases ¹.

- *Outsourcing of APIs*: Many pharmaceutical companies are outsourcing API production to contract manufacturers, leading to growth in the API market ¹.

- *Increasing prevalence of chronic diseases*: The rising incidence of chronic diseases, such as cardiovascular diseases and cancer, is driving demand for APIs ¹.

- *Government initiatives*: Governments are launching initiatives to support API production, such as the Production Linked Incentive (PLI) scheme in India ¹.

- *Mergers and acquisitions*: There is a trend of mergers and acquisitions in the API market, with companies like Teva Pharmaceutical Industries Ltd. and Lonza acquiring other companies to expand their API capabilities ¹.

These trends are expected to drive growth in the API market, with the market size expected to reach USD 6.2 billion by 2024 ².